Difference between revisions of "Example reporting template"

From RSNA Radiology Reporting Initiative
Jump to navigation Jump to search
Line 8: Line 8:
 
COMPARISON: [<date> | None*].
 
COMPARISON: [<date> | None*].
  
TECHNIQUE: [Low-dose helical CT was acquired from lung apices to bases, and reconstructed at 2.5 mm every 1.25 mm, and 1.25 mm every 0.625 mm, without intravenous contrast.]  (DFOV = [ ] cm)
+
TECHNIQUE: [Low-dose helical CT was acquired without intravenous contrast
 +
from lung apices to bases, and reconstructed at 2.5 mm every 1.25 mm,  
 +
and 1.25 mm every 0.625 mm.]  (DFOV = [ ] cm)
  
 
FINDINGS:
 
FINDINGS:
Line 17: Line 19:
 
Size: [# x # cm]
 
Size: [# x # cm]
 
             {if size > 3cm, it's a "mass" and needs staging info}
 
             {if size > 3cm, it's a "mass" and needs staging info}
Composition: [ solid | ground-glass | mixed | calcified | fatty | enhancing | cavitary ]
+
Composition: [ solid | ground-glass | mixed | calcified  
 +
                          | fatty | enhancing | cavitary ]
 
Calcification: [none* | benign pattern | indeterminate]  
 
Calcification: [none* | benign pattern | indeterminate]  
 
             {only if Composition = calcified}
 
             {only if Composition = calcified}
Line 52: Line 55:
 
Detected Incidentally on Nonscreening CT  
 
Detected Incidentally on Nonscreening CT  
  
Adapted from the Fleischner Society Statement on CT of Small Pulmonary Nodules (Radiology 2005;237:395-400)
+
Adapted from the Fleischner Society Statement on CT of Small Pulmonary Nodules
 +
(Radiology 2005;237:395-400)
  
 
Nodule    Low-Risk Patient      High-Risk Patient
 
Nodule    Low-Risk Patient      High-Risk Patient

Revision as of 15:17, 11 June 2009

PROCEDURE: CT CHEST NON-CONTRAST - NODULE PROTOCOL
  {Used for nodules less than 10 mm; generally fewer than 6 nodules; 
   not diffuse nodules;  or for sarcoma metastasis screening.}

CLINICAL INDICATION: [Follow up lung nodule(s)*]. 

COMPARISON: [<date> | None*].

TECHNIQUE: [Low-dose helical CT was acquired without intravenous contrast
from lung apices to bases, and reconstructed at 2.5 mm every 1.25 mm, 
and 1.25 mm every 0.625 mm.]  (DFOV = [ ] cm)

FINDINGS:

Nodules: 

    Nodule: 
	Size: [# x # cm]
            {if size > 3cm, it's a "mass" and needs staging info}
	Composition: [ solid | ground-glass | mixed | calcified 
                          | fatty | enhancing | cavitary ]
	Calcification: [none* | benign pattern | indeterminate] 
            {only if Composition = calcified}
	Location: [ ]   {lung/lobe/segment}
	Image location: series [#] image [#]
	
Other lung findings: [ ]		
		
Airway: [Normal*]

Pleura: [No pleural effusion, thickening or pneumothorax]

Thoracic aorta and great vessels:  [<Normal in diameter.>]

Pulmonary arteries: [Normal*]

Heart and pericardium: [Normal*]

Lymph nodes: [No enlarged thoracic lymph nodes*]

Thoracic spine: [Normal*]

Chest wall: [Normal*]

Visualized upper abdomen: [Normal*]


IMPRESSION:

1.  [< >].


Recommendations for Follow-up and Management of Indeterminate Lung Nodules 
Detected Incidentally on Nonscreening CT 

Adapted from the Fleischner Society Statement on CT of Small Pulmonary Nodules
(Radiology 2005;237:395-400)

Nodule     Low-Risk Patient       High-Risk Patient
 Size
< 4 mm     no follow up needed    follow up CT at 12 months
                                  if unchanged, no follow up

4-8 mm       follow up CT at 6, 12 and 24 months
              if no change, further follow up

> 8 mm     contrast enhanced CT, PET and/or biopsy, OR
           watchful waiting: follow up CT at 3, 9 & 24 months


Notes: diameter = average width; high risk is defined as a history of smoking or other know risk factors for lung cancer; low risk is defined as minimal or absent history of smoking or other known risk factors; caveat: nodules with a ground glass component may require longer follow up to exclude indolent adenocarcinoma